Long-term glycemic variability and risk of peripheral artery disease: a systematic review and meta-analysis of cohort studies.

TL;DR

A meta-analysis of 11 cohort studies found that higher long-term glucose variability was associated with a 42% increased risk of peripheral artery disease (PAD), though substantial study-to-study differences limit certainty about the true magnitude of effect.

What the Study Found

Glucose variability, the day-to-day and week-to-week fluctuations in blood sugar levels, has emerged as a potential risk factor for vascular complications independent of average blood sugar control. This new meta-analysis aggregated data from 11 longitudinal cohort studies to evaluate whether people with higher glucose fluctuations face a greater risk of developing peripheral artery disease, a condition characterized by narrowed arteries in the legs and feet.

The researchers found a consistent signal across studies: participants with high glucose variability had a 42% increased risk of PAD compared to those with low variability (risk ratio 1.42; 95% confidence interval 1.21-1.66). The association held across diverse populations (Asian and Western cohorts), different diabetic statuses (people with and without diabetes), and multiple glucose variability measurement methods. This consistency suggests the finding is not a statistical artifact of one particular study design or population.

However, the analysis revealed substantial heterogeneity between studies, meaning the individual effect sizes varied considerably from study to study. The researchers quantified this variation (I-squared = 91%), indicating that while the overall direction of the association is consistent, the strength differs meaningfully across investigations. Notably, studies with shorter follow-up periods (less than 8 years) reported stronger associations (RR 1.64) than those tracking participants for 8 years or more (RR 1.19). This timing effect raises important questions: does glucose variability have a more pronounced acute effect on PAD risk, or do longer studies capture regression toward the mean? The answer remains unclear from this data alone.

The association persisted even when researchers adjusted for HbA1c, the standard measure of average blood sugar control over three months. This is noteworthy because it suggests glucose variability may influence PAD risk through mechanisms distinct from—or in addition to—sustained hyperglycemia. Whether these mechanisms involve endothelial dysfunction, inflammatory cascades, or oxidative stress remains a topic for future investigation.

What This Means for You

If you have diabetes or prediabetes, this research reinforces the importance of blood sugar stability, not just average levels. Eating high-fiber diet foods, implementing meal timing strategies, and combining protein at every meal can help reduce glucose spikes. Post-meal walk after eating has evidence for blunting glucose excursions.

For people without diabetes, the findings underscore that vascular health depends on multiple factors. Maintaining daily steps target, regular zone-2 cardio, and resistance training all support endothelial function and metabolic stability. Chronic stress reduction through breathwork cyclic sighing or meditation may help regulate glucose patterns.

One important caveat: this meta-analysis establishes association, not causation. It's not yet proven that reducing glucose variability itself prevents PAD. The heterogeneity in study results also means individual responses vary—the true effect size for any given person remains uncertain. Discuss glucose monitoring goals with your healthcare provider, particularly if you have additional PAD risk factors like smoking, hypertension, or elevated cholesterol.

Study Details

Sources

Systematic review and meta-analysis published in PeerJ examining long-term glucose variability and peripheral artery disease risk across 11 cohort studies. PubMed: 42730281